|
|
Article: Hormel Foods, QPP to participate in Mayo Clinic study on use of pig organs in humans.
- Article from:
- Transplant News
- Article date:
- March 31, 1999
CopyrightCOPYRIGHT 1999 Transplant Communications, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Hormel Foods Corporation, Austin, TX and Quality Pork Processors (QPP), in cooperation with the Rochester-based Mayo Clinic, plan to implement a study to determine potential opportunities to utilize pig organs for transplant into humans. The companies say the study of Hormel Food and QPP pork slaughtering and processing workers will help determine whether porcine endogenous retrovirus (PERV), a virus found in all swine, is transferred to people who have a history of extensive exposure to swine tissues and fluids.
The Mayo, Hormel and QPP research is the largest xenotransplantation clinical study to date involving a pork-processing workforce. As part of the ...